>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Calcium Channel>>β-Amino Acid Imagabalin Hydrochloride (PD-0332334)

β-Amino Acid Imagabalin Hydrochloride (PD-0332334) (Synonyms: PD-0332334)

Catalog No.GC31248

&베타;-아미노산 이마가발린 염산염(PD-0332334)(PD-0332334)은 α2δ에 대한 리간드입니다. 전압 의존성 칼슘 채널의 소단위.

Products are for research use only. Not for human use. We do not sell to patients.

β-Amino Acid Imagabalin Hydrochloride (PD-0332334) Chemical Structure

Cas No.: 610300-00-0

Size 가격 재고 수량
1mg
US$1,324.00
재고 있음
5mg
US$2,979.00
재고 있음
10mg
US$5,066.00
재고 있음
20mg
US$8,935.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

β-Amino Acid Imagabalin Hydrochloride (PD-0332334) is a ligand for the α2δ subunit of the voltage-dependent calcium channel.

β-Amino Acid Imagabalin Hydrochloride had been in phase III clinical trials for the treatment of generalised anxiety disorders. However, this research has been discontinued[2]. β-Amino Acid Imagabalin Hydrochloride had been also in phase I clinical trials for the treatment of chronic kidney disease[3].

[1]. Birch M, et al. A Simplified Process for the Manufacture of Imagabalin Hydrochloride (PD-0332334), an α2δ-Ligand for the Treatment of Generalised Anxiety Disorder. Org. Process Res. Dev., 2011, 15 (6), pp 1358-1364

리뷰

Review for β-Amino Acid Imagabalin Hydrochloride (PD-0332334)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for β-Amino Acid Imagabalin Hydrochloride (PD-0332334)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.